Randomised Dabigatran Etexilate Dose Finding Study in Patients With Acute Coronary Syndromes Post Index Event - RE-DEEM

Description:

Evidence regarding the efficacy and safety of the combination of dual antiplatelet therapy and oral anticoagulants in patients with acute coronary syndromes (ACS) is limited. The current trial was a phase II study intended to study the safety and efficacy of four different doses of dabigatran, an oral direct thrombin inhibitor, when given in addition to dual antiplatelet therapy in patients with a recent ST-elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) at high risk of new ...